Assignee
MILESTONE PHARMACEUTICALS INC
CA·8 granted patents·26 pending applications·17 citations·filing 2008–2025
Top patents by PatentIndex Score
34 records- 0192US10117848B2Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2016·Granted Nov 6, 2018·3 cites·39 claims
- 0292US2024366552A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0391US2025090488A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0490US10010523B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2017·Granted Jul 3, 2018·4 cites·1 claims
- 0590US2025332137A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0690US2024115543A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0789US2024277652A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0888US2023414553A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0988US2023255923A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1086US10010522B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2017·Granted Jul 3, 2018·2 cites·1 claims
- 1186US2023157990A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1285US10010524B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2017·Granted Jul 3, 2018·2 cites·4 claims
- 1384US9737503B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2016·Granted Aug 22, 2017·2 cites·4 claims
- 1484US9463179B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2015·Granted Oct 11, 2016·2 cites·12 claims
- 1583US2022296556A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1682US9227918B2Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2014·Granted Jan 5, 2016·2 cites·7 claims
- 1782US2022142963A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1882US2025195462A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1981US2021315855A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2081US2022040139A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2179US2021059972A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2279US2019269643A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2378US2021205258A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2476US2020368195A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2576US2019022048A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2675US2020230097A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2774US2020121631A1Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2874US2019380993A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2972US2019142781A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3071US2018280339A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3171US2026060954A1Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blockerMILESTONE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3268US2010190852A1Short acting phenylalkylamine calcium channel blockers and uses thereofMILESTONE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3365US12257224B2Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blockerMILESTONE PHARMACEUTICALS INC·Filed 2022·Granted Mar 25, 2025·0 cites·22 claims
- 3456US2025228813A1Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blockerMILESTONE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →